KNG1 and angioedema: Some data suggest that ACEi, particularly at higher doses, may offer superior reduction in UAE, whereas ARBs are generally better tolerated and are associated with fewer adverse effects such as cough or angioedema, which are attributed to bradykinin accumulation [7,8,9].